SCHEMBL23769863

SCHEMBL23769863

c1ccc(-c2ccc(-c3ccccc3N(c3cccc(-c4ccc5c(c4)oc4ccccc45)c3)c3cccc4c3-c3ccccc3C4(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
HCRTR1 O43613 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770111 0.98 MMP12 (0.32) MMP12MMP13HCRTR1
SCHEMBL23769943 0.95 MMP12 (0.32) MMP12MMP13HCRTR1
SCHEMBL23769865 0.95 MMP12 (0.32) MMP12MMP13
SCHEMBL23769861 0.95 MMP12 (0.33) MMP12MMP13HCRTR1
SCHEMBL23233136 0.95 CA12 (0.31)
SCHEMBL23770260 0.94 ALOX5 (0.31) MMP12MMP13
SCHEMBL23770278 0.94 PLA2G2A (0.33)
SCHEMBL23770193 0.94 MMP12 (0.32) MMP12MMP13HCRTR1
SCHEMBL23769876 0.94 MMP12 (0.32) MMP12MMP13HCRTR1
SCHEMBL23769809 0.93 MMP12 (0.32) MMP12MMP13HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253546-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253546-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, ESR1, RFT1 MMP12 3995/4885MMP13 3942/4885HCRTR1 2207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.